Found: 6
Select item for more details and to access through your institution.
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 10, p. 2960, doi. 10.1007/s12094-023-03164-y
- By:
- Publication type:
- Article
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study.
- Published in:
- Infectious Agents & Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13027-024-00575-6
- By:
- Publication type:
- Article
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study.
- Published in:
- Infectious Agents & Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13027-024-00575-6
- By:
- Publication type:
- Article
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. 810, doi. 10.1111/apt.17409
- By:
- Publication type:
- Article
Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.783339
- By:
- Publication type:
- Article
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis.
- Published in:
- BJS Open, 2023, v. 7, n. 1, p. 1, doi. 10.1093/bjsopen/zrac167
- By:
- Publication type:
- Article